Florence Lerebours

Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study

Hope S. Rugo, Florence Lerebours, Eva Ciruelos et al. · The Lancet Oncology · 2021 · 349 citations

Medicine, Oncology, Pharmacology +17

Molecular Profiling of Inflammatory Breast Cancer

Ivan Bièche, Florence Lerebours, Sengül Tozlu et al. · Clinical Cancer Research · 2004 · 255 citations · Full text

Medicine, Molecular Biology, Oncology +17

NF-kappa B genes have a major role in Inflammatory Breast Cancer

Florence Lerebours, Sophie Vacher, Catherine Andrieu et al. · BMC Cancer · 2008 · 186 citations · Full text

Medicine, Cancer Biology, Oncology +17

Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional Radiotherapy

Romuald Le Scodan, Denise Stevens, Étienne Brain et al. · Journal of Clinical Oncology · 2009 · 166 citations · Full text

Medicine, Oncology, Surgery +11

Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

Igor Girault, Florence Lerebours, Samira Amarir et al. · PubMed · 2003 · 159 citations

Medicine, Molecular Biology, Oncology +17